Oncologix Tech, Inc. is a medical holding company, which is engaged in the operation and manufacture of medical device products. The company is headquartered in Kentwood, Michigan. The firm has been engaging manufacturers and stakeholders in the industry both in the United States and South Korea to execute agreements with partners, customers, vendors, and manufacturers, reviewing licenses and sublicense agreements with potential licensors, interviewing and hiring employees, and conducting research and due diligence on potential partners, joint-ventures, and acquisitions in the biotech industry. The firm is also seeking additional acquisitions of diagnostic and biotechnology opportunities.
Norwegian Cruise Line Holdings Ltd 最大收入来源是 Passenger Ticket,在最近的收益报告中收入为 6,687,667,000。就地区而言, North America 是 Norwegian Cruise Line Holdings Ltd 的主要市场,收入为 5,649,039,000。
Oncologix Tech Inc 是否盈利?
不,根据最新的财务报表,Norwegian Cruise Line Holdings Ltd 的净损失为 $0